Research graph
References from Engineering a new vaccine platform for heterologous antigen delivery in live-attenuated Mycobacterium tuberculosis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/emmm.201403876
10.1002/emmm.201403876 · External reference
Unresolved reference
External reference
Expression of HBV surface antigen or HIV envelope protein using recombinant adenovirus vectors
1988 · External reference
10.1089/10430349950016762
10.1089/10430349950016762 · External reference
Unresolved reference
External reference
10.1073/pnas.0700869104
10.1073/pnas.0700869104 · External reference
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial
10.1016/s2213-2600(19)30251-6 · 2019 · External reference
Evolutionary landscape of the mycobacterium tuberculosis complex from the viewpoint of PhoPR: Implications for Virulence Regulation and Application to Vaccine Development
10.1128/mbio.01289-15 · 2015 · External reference
10.1046/j.1365-2958.2001.02500.x
10.1046/j.1365-2958.2001.02500.x · External reference
10.1046/j.1365-2958.1999.01593.x
10.1046/j.1365-2958.1999.01593.x · External reference
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials
10.1016/j.vaccine.2013.07.051 · 2013 · External reference
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG
10.1016/j.vaccine.2021.06.049 · 2021 · External reference
10.3389/fimmu.2017.01803
10.3389/fimmu.2017.01803 · External reference
Mycobacterium tuberculosis complex exhibits lineage-specific variations affecting protein ductility and epitope recognition
2016 · External reference
10.1080/14760584.2021.1951243
10.1080/14760584.2021.1951243 · External reference
10.1016/s1473-3099(19)30742-x
10.1016/s1473-3099(19)30742-x · External reference
10.1016/j.cell.2017.12.031
10.1016/j.cell.2017.12.031 · External reference
10.1073/pnas.1202870109
10.1073/pnas.1202870109 · External reference
10.1016/j.chom.2017.12.010
10.1016/j.chom.2017.12.010 · External reference
10.1093/cid/civ144
10.1093/cid/civ144 · External reference
10.1016/j.cell.2020.08.051
10.1016/j.cell.2020.08.051 · External reference
10.1371/journal.ppat.1008404
10.1371/journal.ppat.1008404 · External reference
10.1016/j.cell.2018.08.041
10.1016/j.cell.2018.08.041 · External reference
Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages
10.1371/journal.pone.0012978 · 2010 · External reference
10.1111/febs.15041
10.1111/febs.15041 · External reference
10.1128/9781555818845
10.1128/9781555818845 · 2014 · External reference
10.1038/nmeth996
10.1038/nmeth996 · External reference
10.1038/nmicrobiol.2016.274
10.1038/nmicrobiol.2016.274 · External reference
A crispr-assisted nonhomologous end-joining strategy for efficient genome editing in Mycobacterium tuberculosis
2020 · External reference
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
10.1016/j.omtm.2019.01.014 · 2019 · External reference
BCG vaccination improves DTaP immune responses in mice and is associated with lower pertussis incidence in ecological epidemiological studies
10.1016/j.ebiom.2021.103254 · 2021 · External reference
10.1080/14760584.2018.1445530
10.1080/14760584.2018.1445530 · External reference
Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial
10.1016/j.vaccine.2019.10.105 · 2020 · External reference
New Recombinant Mycobacterium bovis BCG expression vectors: improving genetic control over mycobacterial promoters
10.1128/aem.03677-15 · 2016 · External reference
The PhoP-dependent ncRNA Mcr7 modulates the TAT secretion system in Mycobacterium tuberculosis
10.1371/journal.ppat.1004183 · 2014 · External reference
A specific polymorphism in mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a Novel ESX-1 Component
10.1128/iai.01824-14 · 2014 · External reference
10.1073/pnas.1406693111
10.1073/pnas.1406693111 · External reference
Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro-American genetic background confers optimal vaccine potential
10.1016/j.ebiom.2020.102761 · 2020 · External reference
Reactogenicity to major tuberculosis antigens absent in BCG is linked to improved protection against Mycobacterium tuberculosis
10.1038/ncomms16085 · 2017 · External reference
Unresolved reference
External reference
Unresolved reference
2006 · External reference
10.3390/app10072632
10.3390/app10072632 · External reference
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
10.1038/s41541-020-00262-8 · 2021 · External reference
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial
10.1016/s2213-2600(15)00435-x · 2015 · External reference
Unresolved reference
External reference
10.1016/s1473-3099(17)30390-0
10.1016/s1473-3099(17)30390-0 · External reference
10.1016/j.micinf.2007.10.010
10.1016/j.micinf.2007.10.010 · External reference
Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice
10.1128/iai.68.9.4877-4883.2000 · 2000 · External reference
Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin
10.1128/iai.69.2.869-874.2001 · 2001 · External reference
10.1016/j.vaccine.2003.08.017
10.1016/j.vaccine.2003.08.017 · External reference
Protection against leptospirosis conferred by Mycobacterium bovis BCG expressing antigens from Leptospira interrogans
10.1016/j.vaccine.2020.10.086 · 2020 · External reference
10.1128/jb.00749-08
10.1128/jb.00749-08 · External reference
C-Terminal Signal Sequence Promotes Virulence Factor Secretion in Mycobacterium tuberculosis
10.1126/science.1131167 · 2006 · External reference
10.4014/jmb.1501.01028
10.4014/jmb.1501.01028 · External reference
Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A
10.1084/jem.180.6.2277 · 1994 · External reference
10.1073/pnas.1402981111
10.1073/pnas.1402981111 · External reference
10.1073/pnas.2020368118
10.1073/pnas.2020368118 · External reference
BCG as a case study for precision vaccine development: Lessons from vaccine heterogeneity, trained immunity, and immune ontogeny
10.3389/fmicb.2020.00332 · 2020 · External reference
10.1016/j.chom.2018.12.006
10.1016/j.chom.2018.12.006 · External reference
Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections
10.1128/iai.46.2.422-428.1984 · 1984 · External reference
Lack of a synergistic effect of a non-viral ALS gene therapy based on BDNF and a TTC fusion molecule
10.1186/1750-1172-6-10 · 2011 · External reference
